Skip to main content
Fig. 5 | Genes & Nutrition

Fig. 5

From: Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment

Fig. 5

From Bachawal et al. (2010a), with permission. Effects of combined γ-tocotrienol and erlotinib or gefitinib treatment on +SA cell growth (a, c) and ErbB receptor levels (b, d). Vertical bars indicate the viable cell count ±SEM in each treatment group. *P < 0.05 as compared to vehicle-treated control group (a, c). Western blot analysis measured total and phosphorylated levels of ErbB3 and ErbB4 receptors and α-tubulin levels (b, d). α-Tubulin was visualized to ensure equal sample loading in each lane. Each Western blot is a representative image of data obtained for experiments that were repeated at least three times

Back to article page